about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
8.50
0.08
(0.95%)
2,448
XNAS Volume
XNAS 16 Jul, 2025 3:39 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..